The Prevalence and Characteristics of Obesity among Inpatients with Schizophrenia in Taiwan

台灣精神分裂症住院病人肥胖盛行率及其特性

10.29478/TJP.201203.0005

吳孟寰(Meng-Huan Wu)；景瀚儀(Han-Yi Ching)；吳聖良(Shang-Liang Wu)；張介信(Chieh-Hsing Chang)；陳俊鶯(Chung-Ying Chen)；張達人(Ta-Jen Chang)

精神分裂病 ； 住院病患 ； 肥胖 ； 盛行率 ； prevalence ； obesity ； inpatients ； schizophrenia

台灣精神醫學

26卷1期（2012 / 03 / 01）

5+47 - 53

英文

Objectives: This study was intended to investigate the prevalence and characteristics of obesity and abdominal obesity among inpatients with schizophrenia, and to compare with outpatients and persons in the general population. Methods: We recruited 710 patients with schizophrenia from chronic wards in a mental hospital in Taiwan in March 2010. Obesity and abdominal obesity were defined as the body mass index (BMI) ≥ 27 as well as waist circumference ＞ 90 cm in male, and ＞ 80 cm in female patients, respectively, by the definition set by the Department of Health, Executive Yuan, Taiwan 2002. Results: We analyzed demographic characteristics of 710 participants, including 426 male (60%) and 284 female (40%) patients. The mean age was 47.6 ± 9.5 years and the mean age of onset of the disease was 32.7 ± 10 years. The average length of illness was 14.9 ± 6.8 years, while the mean length of hospitalization was 4.6 ± 2.9 years. The overall prevalence of obesity was 16.4%, with 14.3% in male and 19.7% in female patients, respectively. The overall prevalence of abdominal obesity was 53.8%, with 39.7% in male and 75% in female patients. Conclusion: The prevalence of abdominal obesity among schizophrenic inpatients was higher than that among persons in the general population. Female inpatients had 2.2-fold higher prevalence of abdominal obesity than persons in the general population. Therefore, we suggested that active prevention and intervention for abdominal obesity among inpatients with schizophrenia on chronic wards in Taiwan are needed.

Objectives: This study was intended to investigate the prevalence and characteristics of obesity and abdominal obesity among inpatients with schizophrenia, and to compare with outpatients and persons in the general population. Methods: We recruited 710 patients with schizophrenia from chronic wards in a mental hospital in Taiwan in March 2010. Obesity and abdominal obesity were defined as the body mass index (BMI) ≥ 27 as well as waist circumference ＞ 90 cm in male, and ＞ 80 cm in female patients, respectively, by the definition set by the Department of Health, Executive Yuan, Taiwan 2002. Results: We analyzed demographic characteristics of 710 participants, including 426 male (60%) and 284 female (40%) patients. The mean age was 47.6 ± 9.5 years and the mean age of onset of the disease was 32.7 ± 10 years. The average length of illness was 14.9 ± 6.8 years, while the mean length of hospitalization was 4.6 ± 2.9 years. The overall prevalence of obesity was 16.4%, with 14.3% in male and 19.7% in female patients, respectively. The overall prevalence of abdominal obesity was 53.8%, with 39.7% in male and 75% in female patients. Conclusion: The prevalence of abdominal obesity among schizophrenic inpatients was higher than that among persons in the general population. Female inpatients had 2.2-fold higher prevalence of abdominal obesity than persons in the general population. Therefore, we suggested that active prevention and intervention for abdominal obesity among inpatients with schizophrenia on chronic wards in Taiwan are needed.

1. Allison, DB,Casey, DE(2001).Antipsychotic-induced weight gain: a review of the literature.J Clin Psychiatry,62,22-31.
2. Allison, DB,Newcomer, JW,Dunn, AL(2009).Obesity among those with mental disorders: a National Institute of Mental Health meeting report.Am J Prev Med,36,341-50.
3. Auquier, P,Lançon, C,Rouillon, F,Lader, M(2007).Mortality in schizophrenia.Pharmacoepidemiol Drug Saf,16,1308-12.
4. Bell, RC,Farmer, S,Ries, R,Srebnik, D(2009).Metabolic risk factors among medicaid outpatients with schizophrenia receiving second-generation antipsychotics.Psychiatr Serv,60,1686-9.
5. Bigaard, J,Frederikse, K,Tjønneland, A(2005).Waist circumference and body composition in relation to all-cause mortality in middle-aged men and women.Int J Obes,29,778-84.
6. Bobes, J,Arango, C,Aranda, P,Carmena, R,Garcia-Garcia, M,Rejas, J(2007).Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study.Schizophr Res,90,162-73.
7. Brown, S,Inskip, H,Barraclough, B(2000).Causes of the excess mortality of schizophrenia.Br J Psychiatry,177,212-7.
8. Choi, SB,Jang, JS,Park, S(2005).Estrogen and exercise may enhance beta-cell function and mass via IRS2 induction in ovariectomized diabetic rats.Endocrinology,146,4786-94.
9. Colton, CW,Manderscheid, RW(2006).Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states.Prev Chronic Dis,3,A42.
10. Coodin, S(2001).Body mass index in persons with schizophrenia.Can J Psychiatry,46,549-55.
11. De Hert, MA,Winkel, R,Van Eyck, D(2006).Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication.Schizophr Res,83,87-93.
12. Duvnjak, L,Duvnjak, M(2009).The metabolic syndrome- an ongoing story.J Physiol Pharmacol,60,19-24.
13. Gerozissis, K(2008).Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies.Eur J Pharmacol,585,38-49.
14. Hakko, H,Komulainen, M,Koponen, H(2006).Are females at special risk of obesity if they become psychotic? the longitudinal Northern Finland 1966 Birth Cohort Study.Schizophr Res,84,15-9.
15. Hsiao, CC,Ree, SC,Chiang, YL,Yeh, SS,Chen, CK(2004).Obesity in schizophrenic outpatients receiving antipsychotics in Taiwan.Psychiatry Clin Neurosci,58,403-9.
16. Huang, MC,Lu, ML,Tsai, CJ(2009).Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan.Acta Psychiatr Scand,120,274-80.
17. Kuruvilla, A,Peedicayil, J,Srikrishna, G,Kuruvilla, K,Kanagasabapathy, AS(1992).A study of serum prolactin in schizophrenia: comparison of males and females.Clin Exp Pharmacol Physiol,19,603-6.
18. Kurzthaler, I,Fleischhacker, W(2001).The clinical implications of weight gain in schizophrenia.J Clin Psychiatry,62,32-7.
19. McEvoy, JP,Meyer, JM,Goff, DC(2005).Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.Schizophr Res,80,19-32.
20. Must, A,Spadano, J,Coakley, EH,Field, AE,Colditz, G,Dietz, WH(1999).The disease burden associated with overweight and obesity.JAMA,282,1523-9.
21. Osby, U,Correia, N,Brandt, L,Ekbom, A,Sparén, P(2000).Mortality and causes of death in schizophrenia in Stockholm county, Sweden.Schizophr Res,29,21-8.
22. Oud, MJ,Jong, BM(2009).Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care.BMC Fam Pract,10,32.
23. Park, S,Sang, MH,Il, SA,Sung, HK(2010).Olanzapine, not resperidone, exacerbates beta-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them.J Psychopharmacol,24,1105-14.
24. Poulin, MJ,Chaput, JP,Simard, V(2007).Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.Aust N Z Psychiatry,41,980-9.
25. Reist, C,Mintz, J,Albers, LJ,Jamal, MM,Szabo, S,Ozdemir, V(2007).Second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia: an observational pharmacoepidemiology study from 1988 to 2002.Clin Psychopharmacol,27,46-51.
26. Smith, S,Wheeler, MJ,Murray, R,O''Keane, V(2002).The effect of antipsychotic-induced hyperprolactinemia on the hypothalamic-pituitary-gonadal axis.J Clin Psychopharmacol,22,109-14.
27. Sugawara, N,Yasui-Furukori, N,Sato, Y(2011).Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia.Ann Gen Psychiatry,10,21.
28. Taylor, TL,Killaspy, H,Wright, C(2009).A systematic review of the international published literature relating to quality of institutional care for people with longer term mental health problems.BMC Psychiatry,9,55.
29. Wei, M,Gaskill, S,Haffner, SM,Stern, MP(1997).Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans: a 7-year prospective study.Obes Res,5,16-23.
30. Wieck, A,Haddad, PM(2003).Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences.Br J Psychiatry,182,199-204.
31. Yeh, CJ,Chang, HY,Pan, WH(2011).Time trend of obesity, the metabolic syndrome and related dietary pattern in Taiwan: from NAHSIT 1993-1996 to NAHSIT 2005-2008.Asia Pac J Clin Nutr,20,292-300.